Why the study?
Does genetic deletion or pharmacological inhibition of the Mas receptor impair endothelial function in murine and human models?
Does genetic deletion or pharmacological inhibition of the Mas receptor impair endothelial function in murine and human models?
The G protein-coupled receptor Mas is essential for preserving normal endothelium-dependent vascular relaxation, highlighting Mas agonists as potential therapeutic targets for cardiovascular diseases characterized by endothelial dysfunction.
Answers are grounded in this paper and cite their sources.
Mas inhibition impairs endothelial relaxation in preclinical models; hypothesis-generating for Mas agonists in endothelial dysfunction.
BACKGROUND: Endothelial dysfunction is an initial step in the pathogenesis of cardiovascular diseases. Since we previously identified the G protein-coupled receptor Mas as a receptor for angiotensin (Ang)-(1-7), a heptapeptide with endothelium-dependent vasorelaxant properties, we investigated whether alterations on the Ang-(1-7)/Mas axis alter endothelial function. RESULTS: Ang-(1-7)-mediated relaxation of murine wild-type mesenteric arteries was equally impaired in both wild-type arteries pretreated with the Ang-(1-7) receptor blocker, A779, and arteries isolated from Mas-deficient mice. Importantly, the response to the endothelium-dependent vasorelaxant, bradykinin (BK), and acetylcholine (ACh) effects were comparably inhibited, while endothelium-independent vessel relaxation by sodium nitroprusside was unaltered in these vessels. Hypothesizing endothelial dysfunction, we proved the in-vivo relevance of the ex-vivo findings investigating mesenteric properties after 1 week of minipump infusion of A779 in wild-type mice. Both BK- and ACh-induced relaxation were significantly impaired in wild-type vessels of pretreated animals. A779-induced impairment of endothelial function was confirmed in vitro, since BK-mediated nitric oxide (NO) release was increased by Ang-(1-7) and blunted by A779 pretreatment in primary human endothelial cell cultures. CONCLUSIONS: Our data highlight a pivotal role for the receptor Mas in preserving normal vascular relaxation. Consequently, Mas agonists arise as a promising tool in the treatment of cardiovascular diseases characterized by endothelial dysfunction.
No takes yet. Share an insight, caveat, or question.
Peiró et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: